While there is tremendous excitement and ample investment around cell and gene therapy and regenerative medicine, several challenges, including scale-up, high manufacturing costs, and regulatory hurdles, continue to be impediments to the industry achieving its potential.
5 Questions with Dan Gincel, PhD, Executive Director, MD Stem Cell Research Fund at TEDCO “5 Questions With……” is a weekly BioBuzz series where we reach out to interesting people [….]
This hands-on training workshop is ideal for research and translational biology scientists who are looking for a balanced theoretical vs. hands-on introduction to isolation, quantitation, analysis and engineering of exosomes. [….]
Baltimore’s Gemstone Biotherapeutics Poised to Transform Wound Care Market October 16, 2018 In the U.S. alone, there are over 100 million chronic wound visits every year. By 2020, the general [….]
Regenerative Medicine Leaders Emphasized a Focus on Efficiencies and Collaboration to Make a Greater Impact on Patients
Regenerative Medicine Leaders Emphasized a Focus on Efficiencies and Collaboration to Make a Greater Impact on Patients “We are here to bring the Community together to change the world!” opened [….]